M J Glennie Selected Research

M J Glennie Research Topics

6	Neoplasms (Cancer) 05/2010 - 01/2000
3	Lymphoma (Lymphomas) 11/2000 - 01/2000
1	Cytokine Release Syndrome 03/2014
1	Renal Cell Carcinoma (Grawitz Tumor) 02/2002
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2000
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2000
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2000

3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2002 - 11/2000
3	Monoclonal AntibodiesIBA 02/2002 - 01/2000
3	AntigensIBA 02/2002 - 01/2000
2	CytokinesIBA 03/2014 - 11/2000
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2002 - 02/2001
2	Rituximab (Mabthera)FDA Link 02/2001 - 01/2000
2	Bispecific AntibodiesIBA 02/2001 - 11/2000
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2001 - 11/2000
1	LipopolysaccharidesIBA 03/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2014
1	LigandsIBA 03/2014
1	Interleukin-6 (Interleukin 6)IBA 03/2014
1	Complement System Proteins (Complement)IBA 02/2002
1	ErbB Receptors (EGF Receptor)IBA 02/2002
1	Trastuzumab (Herceptin)FDA Link 02/2001
1	Fc Receptors (Fc Receptor)IBA 02/2001
1	AntibodiesIBA 02/2001
1	Immunoglobulin G (IgG)IBA 02/2001
1	VaccinesIBA 02/2001
1	Immunoglobulin Idiotypes (Idiotype, Immunoglobulin)IBA 11/2000
1	Alemtuzumab (Campath)FDA Link 01/2000
1	antineoplaston A10 (A 10)IBA 01/2000

3	Therapeutics 05/2010 - 01/2000